Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China
Clinical trial NCT06422117 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06422117
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2027-07-30
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.